439 related articles for article (PubMed ID: 17222367)
1. [Correlation of p38 mitogen-activated protein kinase signal transduction pathway to uPA expression in breast cancer].
Han YC; Zeng XX; Wang R; Zhao Y; Li BL; Song M
Ai Zheng; 2007 Jan; 26(1):48-53. PubMed ID: 17222367
[TBL] [Abstract][Full Text] [Related]
2. Integrin β3 and its ligand regulate the expression of uPA through p38 MAPK in breast cancer.
Wang R; Li ZQ; Han X; Li BL; Mi XY; Sun LM; Song M; Han YC; Zhao Y; Wang EH
APMIS; 2010 Dec; 118(12):909-17. PubMed ID: 21091771
[TBL] [Abstract][Full Text] [Related]
3. [Study of the relationship between early growth response gene 1 activity in p38 mitogen-activated protein kinase pathway and epirubicin resistance of human breast carcinoma cells].
Xiao L; Hu JL; Cui W
Zhonghua Bing Li Xue Za Zhi; 2009 Jun; 38(6):408-13. PubMed ID: 19781349
[TBL] [Abstract][Full Text] [Related]
4. DJ-1 promotes invasion and metastasis of pancreatic cancer cells by activating SRC/ERK/uPA.
He X; Zheng Z; Li J; Ben Q; Liu J; Zhang J; Ji J; Yu B; Chen X; Su L; Zhou L; Liu B; Yuan Y
Carcinogenesis; 2012 Mar; 33(3):555-62. PubMed ID: 22223849
[TBL] [Abstract][Full Text] [Related]
5. Involvement of ERK1/2 and p38 MAP kinase in doxorubicin-induced uPA expression in human RC-K8 lymphoma and NCI-H69 small cell lung carcinoma cells.
Niiya M; Niiya K; Shibakura M; Asaumi N; Yoshida C; Shinagawa K; Teshima T; Ishimaru F; Ikeda K; Tanimoto M
Oncology; 2004; 67(3-4):310-9. PubMed ID: 15557793
[TBL] [Abstract][Full Text] [Related]
6. Evodiamine induces apoptosis and inhibits metastasis in MDA‑MB-231 human breast cancer cells in vitro and in vivo.
Du J; Wang XF; Zhou QM; Zhang TL; Lu YY; Zhang H; Su SB
Oncol Rep; 2013 Aug; 30(2):685-94. PubMed ID: 23708383
[TBL] [Abstract][Full Text] [Related]
7. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
Xue A; Xue M; Jackson C; Smith RC
Int J Biochem Cell Biol; 2009; 41(8-9):1731-8. PubMed ID: 19433314
[TBL] [Abstract][Full Text] [Related]
8. Growth factor-dependent activation of the MAPK pathway in human pancreatic cancer: MEK/ERK and p38 MAP kinase interaction in uPA synthesis.
Lee KH; Hyun MS; Kim JR
Clin Exp Metastasis; 2003; 20(6):499-505. PubMed ID: 14598883
[TBL] [Abstract][Full Text] [Related]
9. Urokinase-type plasminogen activator resulting from endometrial carcinogenesis enhances tumor invasion and correlates with poor outcome of endometrial carcinoma patients.
Huang CY; Chang MC; Huang WY; Huang CT; Tang YC; Huang HD; Kuo KT; Chen CA; Cheng WF
Sci Rep; 2015 Jun; 5():10680. PubMed ID: 26033187
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression.
Das R; Philip S; Mahabeleshwar GH; Bulbule A; Kundu GC
IUBMB Life; 2005 Jun; 57(6):441-7. PubMed ID: 16012053
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of emodin on migration, invasion and metastasis of human breast cancer MDA-MB-231 cells in vitro and in vivo.
Sun Y; Wang X; Zhou Q; Lu Y; Zhang H; Chen Q; Zhao M; Su S
Oncol Rep; 2015 Jan; 33(1):338-46. PubMed ID: 25370743
[TBL] [Abstract][Full Text] [Related]
12. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K
Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628
[TBL] [Abstract][Full Text] [Related]
13. Regulation of hepatocyte growth factor-mediated urokinase plasminogen activator secretion by MEK/ERK activation in human stomach cancer cell lines.
Lee KH; Choi EY; Kim MK; Hyun MS; Jang BI; Kim TN; Kim SW; Song SK; Kim JH; Kim JR
Exp Mol Med; 2006 Feb; 38(1):27-35. PubMed ID: 16520550
[TBL] [Abstract][Full Text] [Related]
14. (-)-Epigallocatechin gallate derivatives reduce the expression of both urokinase plasminogen activator and plasminogen activator inhibitor-1 to inhibit migration, adhesion, and invasion of MDA-MB-231 cells.
Shin S; Kim MK; Jung W; Chong Y
Phytother Res; 2018 Oct; 32(10):2086-2096. PubMed ID: 30009577
[TBL] [Abstract][Full Text] [Related]
15. Regulation by p38 mitogen-activated protein kinase of adenylate- and uridylate-rich element-mediated urokinase-type plasminogen activator (uPA) messenger RNA stability and uPA-dependent in vitro cell invasion.
Montero L; Nagamine Y
Cancer Res; 1999 Oct; 59(20):5286-93. PubMed ID: 10537311
[TBL] [Abstract][Full Text] [Related]
16. Urokinase plasminogen activator/urokinase-specific surface receptor expression and matrix invasion by breast cancer cells requires constitutive p38alpha mitogen-activated protein kinase activity.
Huang S; New L; Pan Z; Han J; Nemerow GR
J Biol Chem; 2000 Apr; 275(16):12266-72. PubMed ID: 10766865
[TBL] [Abstract][Full Text] [Related]
17. Baicalin suppresses migration, invasion and metastasis of breast cancer via p38MAPK signaling pathway.
Wang XF; Zhou QM; Du J; Zhang H; Lu YY; Su SB
Anticancer Agents Med Chem; 2013 Jul; 13(6):923-31. PubMed ID: 23387975
[TBL] [Abstract][Full Text] [Related]
18. Phosphatidylinositol 3-kinase/Akt regulates the balance between plasminogen activator inhibitor-1 and urokinase to promote migration of SKOV-3 ovarian cancer cells.
Whitley BR; Beaulieu LM; Carter JC; Church FC
Gynecol Oncol; 2007 Feb; 104(2):470-9. PubMed ID: 17070899
[TBL] [Abstract][Full Text] [Related]
19. P38 MAPK pathway is involved in the urokinase plasminogen activator expression in human gastric SNU-638 cells.
Shin BA; Yoo HG; Kim HS; Kim MH; Hwang YS; Chay KO; Lee KY; Ahn BW; Jung YD
Oncol Rep; 2003; 10(5):1467-71. PubMed ID: 12883725
[TBL] [Abstract][Full Text] [Related]
20. Stromal cell-derived factor-1 (SDF-1) enhances cells invasion by αvβ6 integrin-mediated signaling in ovarian cancer.
Xue B; Wu W; Huang K; Xie T; Xu X; Zhang H; Qi C; Ge J; Yu Y
Mol Cell Biochem; 2013 Aug; 380(1-2):177-84. PubMed ID: 23615713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
